Burke T, Loukitcheva A, Zemansky J, Wheeler R, Boneca I, Portnoy D
J Bacteriol. 2014; 196(21):3756-67.
PMID: 25157076
PMC: 4248804.
DOI: 10.1128/JB.02053-14.
MacLennan C, Gondwe E, Msefula C, Kingsley R, Thomson N, White S
J Clin Invest. 2008; 118(4):1553-62.
PMID: 18357343
PMC: 2268878.
DOI: 10.1172/JCI33998.
Gnarpe H, Edebo L
Infect Immun. 1970; 1(3):300-4.
PMID: 16557732
PMC: 415896.
DOI: 10.1128/iai.1.3.300-304.1970.
Russo T, Moffitt M, HAMMER C, Frank M
Infect Immun. 1993; 61(8):3578-82.
PMID: 8392976
PMC: 281046.
DOI: 10.1128/iai.61.8.3578-3582.1993.
Lie O
Acta Vet Scand. 1980; 21(3):448-50.
PMID: 7446325
PMC: 8317747.
Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.
Demonty J, De Graeve J
Med Microbiol Immunol. 1982; 170(4):265-77.
PMID: 7048047
DOI: 10.1007/BF02123317.
Killing of Listeria monocytogens by conventional and germfree rat sera.
Czuprynski C, Balish E
Infect Immun. 1981; 33(2):348-54.
PMID: 6792076
PMC: 350705.
DOI: 10.1128/iai.33.2.348-354.1981.
Determination of serum bactericidal activity with the aid of luminous bacteria.
Barak M, Ulitzur S, Merzbach D
J Clin Microbiol. 1983; 18(2):248-53.
PMID: 6619281
PMC: 270786.
DOI: 10.1128/jcm.18.2.248-253.1983.
Serum sensitivity of a Pseudomonas aeruginosa mucoid strain.
Schiller N, Alazard M, Borowski R
Infect Immun. 1984; 45(3):748-55.
PMID: 6432698
PMC: 263361.
DOI: 10.1128/iai.45.3.748-755.1984.
Immunological aspects of coliform mastitis.
Carroll E
Vet Res Commun. 1983; 7(1-4):247-52.
PMID: 6364549
DOI: 10.1007/BF02228627.
Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
Taylor P
Microbiol Rev. 1983; 47(1):46-83.
PMID: 6343827
PMC: 281561.
DOI: 10.1128/mr.47.1.46-83.1983.
Killing of an encapsulated strain of Escherichia coli by human serum.
Taylor P, Kroll H
Infect Immun. 1983; 39(1):122-31.
PMID: 6185430
PMC: 347913.
DOI: 10.1128/iai.39.1.122-131.1983.
Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.
MARTINEZ R, Carroll S
Infect Immun. 1980; 28(3):735-45.
PMID: 6156906
PMC: 551012.
DOI: 10.1128/iai.28.3.735-745.1980.
The effect of iron and transferrin on the killing of Escherichia coli in fresh serum.
Fletcher J
Immunology. 1971; 20(4):493-500.
PMID: 4994865
PMC: 1455997.
The serum bactericidal system: ultrastructural changes in Neisseria meningitidis exposed to normal rat serum.
Swanson J, Goldschneider I
J Exp Med. 1969; 129(1):51-79.
PMID: 4973309
PMC: 2138591.
DOI: 10.1084/jem.129.1.51.
Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction.
Feingold D, Goldman J, Kuritz H
J Bacteriol. 1968; 96(6):2118-26.
PMID: 4972918
PMC: 252565.
DOI: 10.1128/jb.96.6.2118-2126.1968.
The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.
Howard C, GLYNN A
Immunology. 1971; 20(5):767-77.
PMID: 4950867
PMC: 1455862.
Lesions in Escherichia coli cell walls caused by the action of mouse complement.
Medhurst F, GLYNN A, Dourmashkin R
Immunology. 1971; 20(4):441-50.
PMID: 4928548
PMC: 1456003.
[Serum resistance and "nephropathogenicity" of antigenically defined strains of E. coli. I. Determination and standardization of serum sensitivity].
Henkel W
Z Med Mikrobiol Immunol. 1970; 156(1):44-59.
PMID: 4921691
The effect of acriflavine on complement sensitive and resistant strains of Escherichia coli and on complement resistant mutants.
GLYNN A, Priest C
Immunology. 1970; 18(1):19-22.
PMID: 4903984
PMC: 1455506.